Professional Documents
Culture Documents
Psychotherapeutic agent related to chlordiazepoxide; reportedly superior in antianxiety and anticonvulsant activity, with
somewhat shorter duration of action. Like chlordiazepoxide, it appears to act at both limbic and subcortical levels of CNS.
Used adjunctively for relief of skeletal muscle spasm associated with tetanus.
Injectable form:
Shock, coma, acute alcohol intoxication, depressed vital signs, obstetrical patients, infants <30 d of age. Tablet form: Infants <6
mo of age, acute narrow-angle glaucoma, untreated open-angle glaucoma; during or within 14 d of MAO inhibitor therapy. Safe
use during pregnancy (category D) and lactation is not established.
Body
Whole: Throat and chest pain.
CNS: Drowsiness, fatigue, ataxia, confusion, paradoxic rage, dizziness, vertigo, amnesia, vivid dreams, headache, slurred speech,
tremor; EEG changes, tardive dyskinesia.
CV: Hypotension, tachycardia, edema, cardiovascular collapse
Spec Senses: Blurred vision, diplopia, nystagmus.
GI: Xerostomia, nausea, constipation, hepatic dysfunction.
Urogenital: Incontinence, urinary retention, gynecomastia (prolonged use), menstrual irregularities, ovulation failure.
Respiratory: Hiccups, coughing, laryngospasm.
Other: Pain, venous thrombosis, phlebitis at injection site.
Monitor for adverse reactions. Most are dose related. Physician will rely on accurate observation and reports of patient response
to the drug to determine lowest effective maintenance dose.
Monitor for therapeutic effectiveness. Maximum effect may require 12 wk; patient tolerance to therapeutic effects may develop
after 4 wk of treatment.
Observe necessary preventive precautions for suicidal tendencies that may be present in anxiety states accompanied by
depression.
Observe patient closely and monitor vital signs when diazepam is given parenterally; hypotension, muscular weakness,
tachycardia, and respiratory depression may occur.
Lab tests: Periodic CBC and liver function tests during prolonged therapy.
Supervise ambulation. Adverse reactions such as drowsiness and ataxia are more likely to occur in older adults and debilitated or
those receiving larger doses. Dosage adjustment may be necessary.
Monitor I&O ratio, including urinary and bowel elimination
DRUG ORDER
MECHANISM OF ACTION
INDICATIONS
CONTRAINDICATIONS
ADVERSE REACTIONS
NURSING IMPLICATIONS
Generic Name & Brand Names
: Baclofen
(bak loe fen)
Lioresal
Pregnancy Category C
Drug class
Centrally acting skeletal muscle relaxant
Dosage & Route
PO 5 mg 3 times/day for 3 days, increased to 10 mg 3 times/day for 3 days
Baclofen is a centrally-acting skeletal muscle relaxant. Baclofen is an antispastic. It inhibits both monosynaptic and polysynaptic
reflexes at spinal level.
Alleviation of signs and symptoms of spasticity resulting from MS, particularly for the relief of flexor spasms and concomitant
pain, clonus, muscular rigidity (for patients with reversible spasticity to aid in restoring residual function
Hypersensitivity. Active peptic ulcer disease.
Sedation, drowsiness, ataxia, dizziness, headache, confusion, hallucinations, skin reactions, GI symptoms, enuresis.
Potentially Fatal: Respiratory or CV depression, seizures.
Give with caution to patients whose spasticity contributes to upright posture or balance in locomotion or whenever spasticity is
used to increase function.
BLACK BOX WARNING: Taper dosage gradually to prevent hallucinations, possible psychosis, or other serious effects; abrupt
discontinuation can cause serious reactions.
Teaching points
Take this drug exactly as prescribed. Do not stop taking this drug without consulting your healthcare provider; abrupt
discontinuation may cause hallucinations or other serious effects.
Avoid alcohol, sleep-inducing, or over-the-counter drugs because these could cause dangerous effects.
.
ASSESSMENT DIAGNOS ANALYSIS PLANNING INTERVENTIO RATIONALE EVALUATION
IS NS
SUBJECTIVE: Pat Acute pain Leptospirosis After 8 hours Explore Cognitive After 8 hours of
ient verbalized related to is a bacterial of nursing alternative behavioural nursing interventions,
of headache bacterial disease that interventions, pain relief interventions the patient was able to
and body pain infections affects the patient measure like may reduce demonstrate use of
OBJECTIVE: in the body humans and will relaxation reliance on relaxation skills, other
Facial animals. It is demonstrate technique, pharmacologic methods to promote
grimacing caused by use of breathing al therapy and comfort and to relieve
Irritability bacteria of the relaxation techniques enhance pain
Guarding genus skills, other and guided patients sense
of the Leptospira. In methods to imagery of control
affectedareas. humans it promote
causes a wide comfort and Carefully Reduces
range of to relieve position discomfort,
symptoms, pain. affected part. and risk for
and some injury.
infected Apply local
persons may massage Help reduce
have no gently to muscle
symptoms at affected tension.
all. Symptoms areas.
of
leptospirosis Encourage
include high range of Prevents joint
fever, severe motion stiffness and
headache, exercises. possible
chills, muscle contracture
aches, and formation.
vomiting, and
may include Maintain Dehydration
jaundice adequate increases
(yellow skin fluid intake. sickling and
and eyes), red
corresponding
eyes,
pain.
abdominal Administer
pain, medication Analgesics
diarrhoea, or as indicated
reduces pain
a rash. like
analgesics and promotes
and rest and
antibiotics comfort, while
antibiotics
inhibits further
bacterial
infection.